Pentoxifylline rescue preserves lung function in isolated canine lungs injured with phorbol myristate acetate

Kevin M. Creamer, Laryssa L. McCloud, Lyle E. Fisher, Ina C. Ehrhart

Research output: Contribution to journalArticle

12 Citations (Scopus)

Abstract

Objective: We hypothesized that pentoxifylline, administered after phorbol myristate acetate (PMA), would diminish the severity of lung injury. Setting: Animal research laboratory. Design: Comparative study. Subjects: Mongrel dogs (n = 33). Interventions: Baseline measurements were obtained from the isolated blood-perfused dog lung lobes after 1 h ofstable perfusion and ventilation. Four different measures of lung compliance were obtained along with WBC and neutrophil counts. Pulmonary vascular resistance (PVR) and capillary filtration coefficient (Kf) were calculated, and the ratio of a normalized maximal enzymatic conversion rate to the Michaelis-Menten constant (Amax/Km) was used to assess perfused capillary surface area. The control lobes (n = 8) were ventilated and perfused for an additional 40 min while the injured lobes (n = 17) received PMA (0.1 μg/mL of perfusate). The pentoxifylline-protected lobes (n = 8) were treated with pentoxifylline (1 mg/mL of perfusate) 10 min after injury with PMA. All measurements were then repeated. Measurement and main results: The three groups did not differ significantly at baseline. The control lobes remained relatively stable over time. The injured lobes demonstrated marked deterioration in compli-ance: 8.79 ± 0.7 to 5.97 ± 0.59 mL/cm H2O (p < 0.05) vs 10.1 ± 1.0 to 8.07 ± 0.72 mL/cm H2O and 9.6 ± 1.1 to 9.9 ± 0.85 mL/cm H2O in the control and protected lobes, respectively. Both groups receiving PMA had similar drops in WBC and neutrophil counts, but the pentoxifylline-protected lobes had preservation of all four compliance measures. PVR increased from 37.8 ± 1.8 to 118.6 ± 12.7 cm H2O/L/min (p < 0.05) in the injured lobes vs 35.4 ± 0.5 to 36.3 ± 2.8 cm H2O/L/min and 40.4 ± 0.04 to 46.7 ± 2.8 cm H2O/L/min (p < 0.05) in the control and protected lobes, respectively. Kf increased < 25% in the protected group but more than tripled in the injured group. Amax/Km dropped from 559 ± 36 to 441 ± 33 mL/min (p < 0.05) in the injured lobes vs 507 ± 14 to 490 ± 17 mL/min and 609 ± 34 to 616 ± 37 mL/min in the control and pentoxifylline-protected lobes, respectively. Conclusions: The use of pentoxifylline as a rescue agent prevented the PMA-induced deterioration of lung compliance, vascular integrity, and endothelial metabolic function in this acute lung injury model, despite significant pulmonary neutrophil sequestration.

Original languageEnglish (US)
Pages (from-to)1893-1900
Number of pages8
JournalChest
Volume119
Issue number6
DOIs
StatePublished - Jun 1 2001

Fingerprint

Pentoxifylline
Tetradecanoylphorbol Acetate
Canidae
Lung
Lung Compliance
Neutrophils
Vascular Resistance
Dogs
Bronchopulmonary Sequestration
Acute Lung Injury
Lung Injury
Compliance
Blood Vessels
Ventilation
Perfusion
Wounds and Injuries

Keywords

  • Acute lung injury
  • Pentoxifylline
  • Phorbol myristate acetate
  • Pulmonary function

ASJC Scopus subject areas

  • Pulmonary and Respiratory Medicine

Cite this

Pentoxifylline rescue preserves lung function in isolated canine lungs injured with phorbol myristate acetate. / Creamer, Kevin M.; McCloud, Laryssa L.; Fisher, Lyle E.; Ehrhart, Ina C.

In: Chest, Vol. 119, No. 6, 01.06.2001, p. 1893-1900.

Research output: Contribution to journalArticle

Creamer, Kevin M. ; McCloud, Laryssa L. ; Fisher, Lyle E. ; Ehrhart, Ina C. / Pentoxifylline rescue preserves lung function in isolated canine lungs injured with phorbol myristate acetate. In: Chest. 2001 ; Vol. 119, No. 6. pp. 1893-1900.
@article{901f590c0ea44e248410c7b71f97636e,
title = "Pentoxifylline rescue preserves lung function in isolated canine lungs injured with phorbol myristate acetate",
abstract = "Objective: We hypothesized that pentoxifylline, administered after phorbol myristate acetate (PMA), would diminish the severity of lung injury. Setting: Animal research laboratory. Design: Comparative study. Subjects: Mongrel dogs (n = 33). Interventions: Baseline measurements were obtained from the isolated blood-perfused dog lung lobes after 1 h ofstable perfusion and ventilation. Four different measures of lung compliance were obtained along with WBC and neutrophil counts. Pulmonary vascular resistance (PVR) and capillary filtration coefficient (Kf) were calculated, and the ratio of a normalized maximal enzymatic conversion rate to the Michaelis-Menten constant (Amax/Km) was used to assess perfused capillary surface area. The control lobes (n = 8) were ventilated and perfused for an additional 40 min while the injured lobes (n = 17) received PMA (0.1 μg/mL of perfusate). The pentoxifylline-protected lobes (n = 8) were treated with pentoxifylline (1 mg/mL of perfusate) 10 min after injury with PMA. All measurements were then repeated. Measurement and main results: The three groups did not differ significantly at baseline. The control lobes remained relatively stable over time. The injured lobes demonstrated marked deterioration in compli-ance: 8.79 ± 0.7 to 5.97 ± 0.59 mL/cm H2O (p < 0.05) vs 10.1 ± 1.0 to 8.07 ± 0.72 mL/cm H2O and 9.6 ± 1.1 to 9.9 ± 0.85 mL/cm H2O in the control and protected lobes, respectively. Both groups receiving PMA had similar drops in WBC and neutrophil counts, but the pentoxifylline-protected lobes had preservation of all four compliance measures. PVR increased from 37.8 ± 1.8 to 118.6 ± 12.7 cm H2O/L/min (p < 0.05) in the injured lobes vs 35.4 ± 0.5 to 36.3 ± 2.8 cm H2O/L/min and 40.4 ± 0.04 to 46.7 ± 2.8 cm H2O/L/min (p < 0.05) in the control and protected lobes, respectively. Kf increased < 25{\%} in the protected group but more than tripled in the injured group. Amax/Km dropped from 559 ± 36 to 441 ± 33 mL/min (p < 0.05) in the injured lobes vs 507 ± 14 to 490 ± 17 mL/min and 609 ± 34 to 616 ± 37 mL/min in the control and pentoxifylline-protected lobes, respectively. Conclusions: The use of pentoxifylline as a rescue agent prevented the PMA-induced deterioration of lung compliance, vascular integrity, and endothelial metabolic function in this acute lung injury model, despite significant pulmonary neutrophil sequestration.",
keywords = "Acute lung injury, Pentoxifylline, Phorbol myristate acetate, Pulmonary function",
author = "Creamer, {Kevin M.} and McCloud, {Laryssa L.} and Fisher, {Lyle E.} and Ehrhart, {Ina C.}",
year = "2001",
month = "6",
day = "1",
doi = "10.1378/chest.119.6.1893",
language = "English (US)",
volume = "119",
pages = "1893--1900",
journal = "Chest",
issn = "0012-3692",
publisher = "American College of Chest Physicians",
number = "6",

}

TY - JOUR

T1 - Pentoxifylline rescue preserves lung function in isolated canine lungs injured with phorbol myristate acetate

AU - Creamer, Kevin M.

AU - McCloud, Laryssa L.

AU - Fisher, Lyle E.

AU - Ehrhart, Ina C.

PY - 2001/6/1

Y1 - 2001/6/1

N2 - Objective: We hypothesized that pentoxifylline, administered after phorbol myristate acetate (PMA), would diminish the severity of lung injury. Setting: Animal research laboratory. Design: Comparative study. Subjects: Mongrel dogs (n = 33). Interventions: Baseline measurements were obtained from the isolated blood-perfused dog lung lobes after 1 h ofstable perfusion and ventilation. Four different measures of lung compliance were obtained along with WBC and neutrophil counts. Pulmonary vascular resistance (PVR) and capillary filtration coefficient (Kf) were calculated, and the ratio of a normalized maximal enzymatic conversion rate to the Michaelis-Menten constant (Amax/Km) was used to assess perfused capillary surface area. The control lobes (n = 8) were ventilated and perfused for an additional 40 min while the injured lobes (n = 17) received PMA (0.1 μg/mL of perfusate). The pentoxifylline-protected lobes (n = 8) were treated with pentoxifylline (1 mg/mL of perfusate) 10 min after injury with PMA. All measurements were then repeated. Measurement and main results: The three groups did not differ significantly at baseline. The control lobes remained relatively stable over time. The injured lobes demonstrated marked deterioration in compli-ance: 8.79 ± 0.7 to 5.97 ± 0.59 mL/cm H2O (p < 0.05) vs 10.1 ± 1.0 to 8.07 ± 0.72 mL/cm H2O and 9.6 ± 1.1 to 9.9 ± 0.85 mL/cm H2O in the control and protected lobes, respectively. Both groups receiving PMA had similar drops in WBC and neutrophil counts, but the pentoxifylline-protected lobes had preservation of all four compliance measures. PVR increased from 37.8 ± 1.8 to 118.6 ± 12.7 cm H2O/L/min (p < 0.05) in the injured lobes vs 35.4 ± 0.5 to 36.3 ± 2.8 cm H2O/L/min and 40.4 ± 0.04 to 46.7 ± 2.8 cm H2O/L/min (p < 0.05) in the control and protected lobes, respectively. Kf increased < 25% in the protected group but more than tripled in the injured group. Amax/Km dropped from 559 ± 36 to 441 ± 33 mL/min (p < 0.05) in the injured lobes vs 507 ± 14 to 490 ± 17 mL/min and 609 ± 34 to 616 ± 37 mL/min in the control and pentoxifylline-protected lobes, respectively. Conclusions: The use of pentoxifylline as a rescue agent prevented the PMA-induced deterioration of lung compliance, vascular integrity, and endothelial metabolic function in this acute lung injury model, despite significant pulmonary neutrophil sequestration.

AB - Objective: We hypothesized that pentoxifylline, administered after phorbol myristate acetate (PMA), would diminish the severity of lung injury. Setting: Animal research laboratory. Design: Comparative study. Subjects: Mongrel dogs (n = 33). Interventions: Baseline measurements were obtained from the isolated blood-perfused dog lung lobes after 1 h ofstable perfusion and ventilation. Four different measures of lung compliance were obtained along with WBC and neutrophil counts. Pulmonary vascular resistance (PVR) and capillary filtration coefficient (Kf) were calculated, and the ratio of a normalized maximal enzymatic conversion rate to the Michaelis-Menten constant (Amax/Km) was used to assess perfused capillary surface area. The control lobes (n = 8) were ventilated and perfused for an additional 40 min while the injured lobes (n = 17) received PMA (0.1 μg/mL of perfusate). The pentoxifylline-protected lobes (n = 8) were treated with pentoxifylline (1 mg/mL of perfusate) 10 min after injury with PMA. All measurements were then repeated. Measurement and main results: The three groups did not differ significantly at baseline. The control lobes remained relatively stable over time. The injured lobes demonstrated marked deterioration in compli-ance: 8.79 ± 0.7 to 5.97 ± 0.59 mL/cm H2O (p < 0.05) vs 10.1 ± 1.0 to 8.07 ± 0.72 mL/cm H2O and 9.6 ± 1.1 to 9.9 ± 0.85 mL/cm H2O in the control and protected lobes, respectively. Both groups receiving PMA had similar drops in WBC and neutrophil counts, but the pentoxifylline-protected lobes had preservation of all four compliance measures. PVR increased from 37.8 ± 1.8 to 118.6 ± 12.7 cm H2O/L/min (p < 0.05) in the injured lobes vs 35.4 ± 0.5 to 36.3 ± 2.8 cm H2O/L/min and 40.4 ± 0.04 to 46.7 ± 2.8 cm H2O/L/min (p < 0.05) in the control and protected lobes, respectively. Kf increased < 25% in the protected group but more than tripled in the injured group. Amax/Km dropped from 559 ± 36 to 441 ± 33 mL/min (p < 0.05) in the injured lobes vs 507 ± 14 to 490 ± 17 mL/min and 609 ± 34 to 616 ± 37 mL/min in the control and pentoxifylline-protected lobes, respectively. Conclusions: The use of pentoxifylline as a rescue agent prevented the PMA-induced deterioration of lung compliance, vascular integrity, and endothelial metabolic function in this acute lung injury model, despite significant pulmonary neutrophil sequestration.

KW - Acute lung injury

KW - Pentoxifylline

KW - Phorbol myristate acetate

KW - Pulmonary function

UR - http://www.scopus.com/inward/record.url?scp=0034889775&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0034889775&partnerID=8YFLogxK

U2 - 10.1378/chest.119.6.1893

DO - 10.1378/chest.119.6.1893

M3 - Article

VL - 119

SP - 1893

EP - 1900

JO - Chest

JF - Chest

SN - 0012-3692

IS - 6

ER -